共 106 条
[1]
Aronson SJ(2015)Building the foundation for genomics in precision medicine Nature 160 1616-20
[2]
Rehm HL(1902)The incidence of Alkaptonuria: a study in chemical individuality Lancet 145 85-101
[3]
Garrod AE(2000)The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging Toxicology 1822 1682-91
[4]
Hegedus ZL(2012)Alkaptonuria is a novel human secondary amyloidogenic disease Biochim Biophys Acta 75 362-7
[5]
Millucci L(2016)Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment Ann Rheum Dis 4 55-65
[6]
Spreafico A(2012)Identification of 11 novel homogentisate 1,2 dioxygenase variants in alkaptonuria patients and establishment of a novel LOVD-based HGD mutation database JIMD Rep 25 585-92
[7]
Tinti L(1998)Serum cystatin C as a marker of the renal function Scand J Clin Lab Invest 39 658-61
[8]
Braconi D(2006)Cystatin C reference values and aging Clin Biochem 40 1084-7
[9]
Ghezzi L(2007)Adult cystatin C reference intervals determined by nephelometric immunoassay Clin Biochem 6 1206-5
[10]
Paccagnini E(2014)Two faces of cathepsin D: physiological guardian angel and pathological demon Biol Med (Aligarh) 280 211-5